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The previous era was characterized by house staff laboratories in every
ward, and house staff and attending physicians often spent long periods
performing a diagnostic examination of the expectorated sputum speci-
men, which had been obtained with great care and plated for prompt in-
cubation in incubators on the ward. Therapeutic decisions were generally
based on these results. During the past 30 years, there has been a nota-
ble decline in the quality of this exercise. Some of this decline can be
ascribed to the Clinical Laboratory Improvement Amendments of 1988,
which required that staff have credentials to interpret Gram stains of any
specimens, thus essentially eliminating the house staff laboratory. Addi-
tional factors in the decline of microbiology were the outsourcing of
specimens, which led to delays in processing and poor communication
between the microbiologist and the physician.
—John G. Bartlett (1).
The responsibility for interpretation of the Gram-stained smear should
not be delegated. Technicians often are highly skilled in the recognition
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of bacteria but may have had little training in the interpretation of back-
ground material and cell types as they appear in Gram-stained smears of
clinical specimens. Furthermore, the laboratory technician is usually not
privy to important clinical facts. . .which may inﬂuence the interpretation
of the smear. Therefore, it is our feeling that the Gram-stained smear
should be considered part of the physical examination of the patient
with an acute bacterial infection and belongs in the repertoire of all phy-
sicians delivering primary care in acutely ill patients.
—Harriet Provine and Pierce Gardner (2).
The preceding passages are direct quotations from papers written by clinicians in2004 (1) and 1974 (reference 2, as quoted in reference 3), which essentially describe
a perceived decline in the quality of laboratory microbiology, particularly as it pertains
to the direct Gram stain examination. How do the bench-level clinical microbiologist,
the doctoral-level medical microbiologist, and the general laboratory professional react
to statements such as these, leveled against one of “our” fundamental, rapid diagnostic
assays? Egocentric statements bellowed from the thrones of clinicians in a never-
ending doctor-versus-laboratory battle? Halcyon days of 1950s infectious diseases (ID)
practice? Offense? Humiliation? An affront? A call to arms? Motivation to change/
improve our practice? One medical microbiologist who, in the eyes of many of his
professional colleagues, has largely assumed the challenge of reversing this trend by
championing the clinical value of the direct Gram stain examination is Richard B. (Tom)
Thomson, Jr., Ph.D., the recipient of the 2017 Sonnenwirth Award for Leadership in
Clinical Microbiology and the subject of this biographical feature.
Tom Thomson was born in 1949. His father, a former World War II ﬂier turned
manufacturing engineer, and mother settled in a newly subdivided area of Saginaw, MI.
In a recent interview, Thomson spoke highly of his parents, exclaiming that “what is
important is having parents that do it right.” Because no one lived near the family at the
time, Thomson spent much of his free time with builders and carpenters who were
erecting new housing developments in the area (perhaps applying his excellent math
and science skills). Thomson considered himself a good student and a good athlete
(soccer, baseball, and basketball) and yet “pathologically shy.” As the local public-
school system was in its infancy, Thomson’s parents elected to send him to Deerﬁeld
Academy in Massachusetts (in the vicinity of a family relative) for grades 10 through 12.
Thomson could not recall the exact thought process that resulted in this decision but
remarked that the school had phenomenal facilities and that matriculation at this
academy was the “best decision ever made from an academic and social position.
Deerﬁeld turned me around as far as reading and writing skills.”
Thomson subsequently entered Trinity College (Hartford, CT) and was graduated
with a baccalaureate degree in biology in 1971. Thomson remarked that the years of
U.S. involvement in the Vietnam War were interesting and difﬁcult times to be a college
student. In serendipitous fashion, the years at Trinity College proved to be the trans-
formative years with respect to Thomson becoming a scientist. A chain of events,
including applying to medical school, receiving a high draft lottery position making
conscription unlikely, and postponing medical school entrance, resulted in Thomson’s
moving to Philadelphia, PA, and taking a technician position at William Pepper Labo-
ratories (Hospital of the University of Pennsylvania [HUP]) despite having never com-
pleted a microbiology course at the collegiate level. It was there that Harry E. Morton,
Sc.D., director of microbiology at HUP and an early American Society for Microbiology
(ASM) leader, personally taught Thomson the craft of clinical microbiology. According
to Thomson, one of Dr. Morton’s philosophies was “give me smart, motivated people
and I can make a microbiologist out of them.” Thomson lauded the carefulness of Dr.
Morton’s science and teaching. James A. Poupard, Ph.D., who was the HUP microbiol-
ogy supervisor at the time, remembered that Thomson’s job application was expedited
“due to his biology degree, interest in medicine, and because Dr. Morton was also a
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native of Michigan and Tom was our ﬁrst applicant from that state.” Dr. Poupard further
remarked that Thomson had “a very ﬂexible personality, was ambitious, and still
maintained that Midwestern Michigan openness. He was initially perceived as naive in
his younger days at HUP and exposed to big city life.” Even at that time, Thomson “was
a quick learner, got along well with the other techs, and liked to teach.” It was here that
he was ﬁrst asked by Dr. Dick Root, head of infectious diseases at HUP, to accompany
the infectious diseases team, with laboratory results in hand, as they made clinical
rounds.
As a result of the 3 years spent in the laboratory at HUP, Thomson decided to forego
medical school and medicine as a career and enter graduate school to become a
medical scientist. Learning that science rather than patient care was his passion was the
transformative moment in his career. His ﬁrst stop was the clinical microbiology
master’s degree program at Thomas Jefferson University. It was through this program
and subsequent association with the Eastern Pennsylvania branch of ASM that Thom-
son ﬁrst met Eileen Randall, Ph.D. (4). At the time, the Philadelphia area was a hotbed
of microbiology talent (5), particularly in application to infectious diseases, and Thom-
son took advantage of this landscape to forge relationships with individuals who were
inﬂuential in his career. Thomson lists as his mentor “an amalgam of people.” Thomson
described Mr. Elvyn Scott, lead microbiologist at the Wilmington (Delaware) Medical
Center, as a kind, gentle, and knowledgeable man “who knew how to get things done.
While being a fastidious scientist, he also understood people.” Thomson credits the
inﬂuence of Mr. Scott toward his own laboratory management skills and ability to
interact with others.
Thomson completed his master’s thesis in 1976 and moved to the Thomas Jefferson
University Department of Microbiology/Immunology for doctoral work. His studies
were focused in the basic sciences (sophisticated electrophoretic techniques designed
to isolate Aspergillus sp. antigens for subsequent pathogenesis and diagnostics studies)
and essentially represented a means to an end. During graduate school, Thomson
“moonlighted” as a clinical microbiologist, as he was employed on weekends as a
clinical microbiology laboratory supervisor in Trenton, NJ, and taught courses in clinical
microbiology at local academic institutions. During these years, Thomson additionally
interacted with William (Bill) Holloway, M.D., an infectious diseases specialist at the
Wilmington Medical Center. Thomson recalled that participation in clinical infectious
diseases rounds with Dr. Holloway helped germinate the seeds ﬁrst planted at HUP by
Dr. Root, illustrating the value of the direct Gram stain in clinical practice. “I was able
to correlate Gram stain with culture result and with what we were seeing bedside.” Dr.
Holloway also organized a local infectious diseases symposium every spring that would
attract national leaders in both infectious diseases and medical microbiology. During
those years, Thomson “met nearly every ID expert and microbiology expert in the U.S.”
One of the experts Thomson met through these interactions was John A. Washing-
ton II, M.D. (6), head of the Mayo Clinic Section of Clinical Microbiology at the time. This
budding relationship spurred Thomson to enter an ASM Committee on Postgraduate
Educational Programs (CPEP)-approved fellowship program at Mayo Clinic in 1980.
Thomson recollected that clinical microbiology at the Mayo Clinic was executed
differently from what he was familiar with. “Their focus was developing the best
scientiﬁc result; their delivery lacked a consultative component.” Thomson subse-
quently infused his developing clinical interactive skills into delivery of microbiology
ﬁndings. Thomas F. Smith, Ph.D. (7), emeritus chair of the Division of Clinical Microbi-
ology at Mayo Clinic, stated that “Dr. Thomson throughout his career emphasized the
role of the clinical microbiologist in interacting with the clinician regarding the impli-
cation of laboratory results. He always had a close relationship with clinicians so they
could take the proper approach together. That’s the way he practiced clinical micro-
biology—it was really ideal.” Dr. Smith also credited Thomson as becoming “a gifted
and conversant teacher and having a research perspective in every laboratory during
his rotations.”
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In 1982, Thomson was recruited by Raymond Clarke, M.D., chair of pathology at
Akron (Ohio) City Hospital, to serve as medical microbiologist and director of the clinical
microbiology laboratory at this location as well as director of clinical virology at the
Children’s Hospital Medical Center in Akron. Dr. Clarke wrote, “We needed a microbi-
ologist in Akron—at Akron City Hospital, Akron Children’s Hospital, and the medical
school (Northeast Ohio Medical University). Tom was more than we expected. I still
cannot believe that he came to Akron and stayed as long as he did. As a microbiologist
he raised the quality of talent and productivity of the microbiology lab at Akron City
Hospital, the virology laboratory at Children’s Hospital, and the teaching at the medical
school. Tom raised his position to such a level that it was extremely difﬁcult to ﬁll his
shoes when he left.” In 1991, Thomson succeeded his friend and former mentor Dr.
Randall as director of microbiology laboratories at Evanston Hospital in Evanston, IL
(now known as NorthShore University HealthSystem), and has held variations of this
position for the past 27 years. One of Thomson’s primary collaborators at this institu-
tion, Lance R. Peterson, M.D., professor of medicine and of pathology and laboratory
medicine, remarked that “over the years, Tom has really turned the microbiology
laboratory into a top-level, academic diagnostic laboratory. He is also one of the most
active members of our department in teaching and is one of the most collegial people
at NorthShore, wanting people to collaborate in the effort of improving patient care.”
Thomson himself reﬂected, “I take great satisfaction in having arrived in a lab that had
been without a director for nearly a year and, over time, recruiting and collaborating
with other colleagues to establish one of the most scientiﬁcally productive and clinically
focused clinical microbiology laboratories in the country.”
Several attributes of Thomson have been noted by colleagues as contributing to his
overriding success and excellence in the ﬁelds of clinical and medical microbiology. Dr.
Smith remarked that Thomson “expresses unique views and he is always right!” Dr.
Poupard described Thomson as being sincere yet not afraid to express his opinion. In
support of her primary nomination of Thomson for the Sonnenwirth Award, Dena
Shibib, D.O., assistant professor and associate director of microbiology and virology
laboratories in the University of Oklahoma College of Medicine, cited Thomson’s
genuine enthusiasm for microbiology, positive attitude, approach to problem solving,
and teaching acumen. During her anatomic/clinical pathology residency training at
NorthShore University HealthSystem, Dr. Shibib related that it was Thomson’s daily
microbiology laboratory rounds that inspired her to choose a career in clinical micro-
biology over transfusion medicine. “The rounds were very clinical. In addition to the
organism, we would think about pathogenesis of disease and how the patient may
have acquired the infection. Pharmacy would also chime in on therapeutic options.” Dr.
Shibib also credits Thomson for “opening up the eyes of trainees (and other attending
clinicians) to the fascination and enjoyment of microbiology” and for sometimes
interjecting during the middle of rounds, “Isn’t this fun?” Karen C. Carroll, M.D.,
professor of pathology at Johns Hopkins School of Medicine and editor for Journal of
Clinical Microbiology, ﬁrst met Thomson nearly 20 years ago as part of an invited
laboratory inspection team. She wrote that she was “so impressed by his microbiology
knowledge and mostly by his collegiality, his ability to recognize the contributions of
all members of the team, and his fantastic sense of humor that over the years was used
effectively to diffuse uncomfortable situations. Tom had a knack for bringing groups
back to the question at hand in an objective way.” Dr. Shibib added that if a trainee was
unsure of the answer to a question during laboratory rounds, Thomson “would nicely
let them think about it or gently prompt them.” Irene K. Dusich, M.T., microbiology
laboratory manager at NorthShore University HealthSystem, stated that Thomson takes
his directorship very seriously and demonstrates commitment to patient care, day-to-
day operations of the laboratory, and consultative interactions with bench-level
microbiologists. Finally, Peter H. Gilligan, Ph.D., professor in the Departments of
Microbiology-Immunology and Pathology-Laboratory Medicine at the University of
North Carolina School of Medicine, in summarizing his 4-decade association with
Thomson, wrote that “his willingness to spend his vast knowledge and experience with
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seemingly anyone who needs it to improve their delivery of quality diagnostic micro-
biology is a mark of his kindness and generosity . . . I cannot think of anyone I respect
more in our profession.”
When asked about lasting contributions or innovations made by Thomson, Patrick
R. Murray, Ph.D. (8), senior director of worldwide scientiﬁc affairs, BD Life Sciences,
simply referred to him as a “visionary microbiologist.” Dr. Murray acknowledged
Thomson’s “ability to view technology as a means to do things he has never done
before” and speciﬁcally cites Thomson’s adaptation of molecular diagnostics to the
paradigm of methicillin-resistant Staphylococcus aureus (MRSA) colonization in hospi-
talized patients. Dr. Peterson, a major collaborator in these early efforts, recalled,
“NorthShore was the ﬁrst multihospital system in North America to introduce a uni-
versal MRSA admissions screening program. Tom was very enthusiastic about this
program and was instrumental in getting testing systems organized in just a 2-month
period.” Since the inception of the program (in which approximately 40,000 molecular
MRSA screens are performed on an annual basis) in August 2005, Dr. Peterson has
reported a 70% sustained MRSA disease reduction rate as a result of the program,
leading him to conclude, “we have established a benchmark for overall reduction of
[nosocomial] MRSA disease.” Such efforts have recently been extrapolated to reduction
of nosocomial Clostridium difﬁcile infection at NorthShore University HealthSystem.
Thomson’s contributions to the ﬁelds of medical microbiology and clinical micro-
biology are indeed visionary because they range anywhere from a simple, rapid
staining procedure to those involved in total laboratory automation. As described
previously, Thomson’s interest and fascination with the clinical utility of the direct Gram
stain preparation stem back to his days as an aspiring medical microbiologist in
Philadelphia and continued through his fellowship training at Mayo Clinic. Dr. Smith
stated, “The value of the Gram stain has grown throughout his clinical practice. He
would show series of Gram stains and reveal what sort of information you could
transmit to the clinician in terms of caring for the patient—not just treating the
patient.” When personally queried about the importance of this test, Thomson provided
a rather didactic response. Pattern recognition skills are necessary to appreciate a Gram
stain. “You must train yourself to recognize patterns, so that you know what’s going on
in a second. That’s what I did when I was younger. The ID doctors back in Wilmington
wanted to know what I thought of the Gram stains. However, the ability to do this
[pattern recognition] is not uniform.” Thomson equated this skill to that possessed by
cytopathologists and hematopathologists in terms of rapid and accurate interpreta-
tions of “abnormal/normal” and “malignant/benign” cellular proﬁles. At the same time,
Thomson lamented the fact that this service element of the clinical microbiology
laboratory appears to be “less in demand nowadays” and is “not where it should be” in
terms of overall quality, training, and proﬁciency. Thomson essentially lent support to
the aforementioned commentaries by Bartlett (1) and Provine and Gardner (2) and yet
has attempted to change the paradigm of disconnection between microbiology and
clinical service (sometimes augmented by distantly located, consolidated laboratories
[9]) through his own practice. Dr. Shibib remarked that Thomson is personally “sought
out by clinicians for knowledge and advice.” Dr. Carroll characterized Thomson’s
laboratory as a “model of state-of-the-art microbiology and the impact of daily con-
sultative services on patient care.” Thomson pursues the application of electronic
advancements (electronic consultation and secure transmission of direct Gram stain
digital imagery) toward establishment of real-time communication lines between the
laboratory and clinicians and yet noted that “there is so much we overlook every day
in the delivery of microbiology results.”
Several experts in the ﬁeld view Thomson as a pioneer in total microbiology
laboratory automation. Dr. Murray stated that Thomson, particularly in the context of
early digital interpretation of primary culture plates (10), is “pushing boundaries to see
what can actually be accomplished.” Not only can this be important from an efﬁciency
perspective; Dr. Murray also cites the prospect of “providing clinically relevant infor-
mation as early as possible.” However, when posed with an inquiry to describe the
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impetus for investigating total laboratory automation, Thomson provided an interest-
ing retort. He recalled his early days as a practicing medical microbiologist in Ohio,
when he discovered that his inherited low-ﬁll-volume, semiautomated blood culture
system lacked the necessary sensitivity for detection of clinically signiﬁcant bacteremia.
The system was decommissioned and replaced by a conventional bottle system until
years later, when automation could accommodate a 20-ml blood ﬁll. Thomson also
advocated utilization of spot testing-based identiﬁcation and disk diffusion suscepti-
bility testing methods versus commercial automated identiﬁcation and susceptibility
testing systems on the basis of overall cost and ﬂexibility for tested antimicrobial
agents. These decisions caused him to be labeled antiautomation by peers. (Ms. Dusich,
upon assuming her managerial position in Thomson’s laboratory 12 years ago, remi-
nisced that she had set out to change Thomson’s philosophy regarding automation but
was unsuccessful and has since admitted that disk diffusion testing would now be her
chosen method.) Thomson’s rebuttal to charges of being the least automated and most
old-fashioned laboratory in the region was simple: “Oh, I’ll be automated—just give me
something that works.”
In general, Thomson claims not to be a strong advocate of the consolidated-
microbiology-laboratory paradigm, largely citing issues with specimen integrity
(antibiotic-induced damage of specimens ex vivo and processing delays “signiﬁcantly
impairing what you could be doing on site”). Yet Thomson is of the opinion that this
consolidation paradigm provides a segue for future total microbiology laboratory
automation in every clinical laboratory. He maintains that a business case for “putting
a limited number of total laboratory automated components in remote hospitals where
local plate images are interpreted centrally in a core facility” would be compelling.
Thomson challenges commercial manufacturers of automation to design and build
systems that are modular in nature to meet this future need.
Thomson’s scholarly activities have been evidenced by over 100 publications, more
than 35 book chapters, and numerous abstracts and oral presentations. During the
course of formal presentation, Janet Hindler, M.S., past microbiology specialist at UCLA
Medical Center, stated that Thomson “always explains a topic in the context of what it
means for the patient and how the laboratory can provide the most-meaningful
results.” Thomson has frequently contributed chapters to both Manual of Clinical
Microbiology and Clinical Microbiology Procedures Handbook. He has served on the
editorial boards of journals such as Journal of Clinical Microbiology, Infectious Diseases in
Clinical Practice, and Diagnostic Microbiology and Infectious Disease and is an ad hoc
reviewer for outlets such as Clinical Infectious Diseases, Antimicrobial Agents and Che-
motherapy, and Clinical Microbiology Reviews. Thomson has actively participated in
professional societies such as ASM (chair, Clinical Microbiology Division C, in 2017), the
Illinois Society for Microbiology (Pasteur Award recipient in 2016), the Infectious
Diseases Society of America (Clinical Practice Guidelines Committee—Clinical Microbi-
ology from 2008 to 2012), the American Society for Clinical Pathology, and the Medical
Mycological Society of the Americas. Thomson earned fellowship in the American
Academy of Microbiology in 2005. In recent years, Thomson has been a member of the
College of American Pathologists (CAP) Microbiology Resource Committee. On a per-
sonal note, Thomson feels that the Evanston Hospital House Staff Attending of the Year
Award for 1996-1997 was especially signiﬁcant, as he became the ﬁrst (and only)
nonphysician to receive the honor. “I think that I received this award because of my
consultative interactions. In retrospect, the house staff may not have known that I was
a scientist, not a physician.”
Thomson is also a diplomate of the American Board of Medical Microbiology and has
served as dean of the American College of Microbiology, charged with oversight of all
ASM board certiﬁcation and fellowship training activities. He spoke at length about the
evolution of the ABMM certiﬁcation program, stating that credibility is what built it.
“Early support by M.D. microbiologists expanded credibility of the certiﬁcation into the
medical microbiology community.” More and more clinicians were encouraged to take
the examination not only in terms of positioning themselves favorably during recruit-
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ment but also due to the signiﬁcant role that diplomates play in the medical commu-
nity as a whole. Thomson also chaired the CPEP program from 2004 to 2010. He stated
that the program “transformed clinical microbiology by providing superbly trained
professionals both scientiﬁcally and clinically. Nearly every signiﬁcant discovery/ad-
vancement in the ﬁeld has a vein that goes back to a CPEP trainee.” Thomson was a
voting member of the Clinical and Laboratory Standards Institute (CLSI) Subcommittee
on Antimicrobial Susceptibility Testing from 2008 to 2012 and has held the chair of the
Expert Committee on Microbiology since 2012. Pertinent to this role, Ms. Hindler stated
that Thomson “ensures that CLSI is addressing contemporary needs of clinical micro-
biology through their approved standards and guidelines.” Thomson himself remarked
that CLSI functions differently from other professional societies in that it adds the
element of “consensus based on experience. Here’s what science tells us (approved
standards), but we should be doing so much more—here’s what experience tells us
(consensus guidelines).” Thomson additionally underscored the role of CAP in the
routine function of the clinical microbiology laboratory. “It touches everything we do
every day [accreditation, proﬁciency testing, education, CPT payment]—a lot of us do
not appreciate this.”
In many ways, Thomson’s scholarly activity and service contributions have provided
a template for how bench-level microbiologists and laboratory directors should per-
form their duties. Dr. Gilligan, past editor of the Journal of Clinical Microbiology
Point-Counterpoint feature, summarized, “Dr. Thomson’s generosity has extended to
his willingness to make important contributions to our conversations about our pro-
fession and practice of clinical microbiology. Examples of those contributions can be
found in the pages of this journal. Two in particular stand out. In one [11], Dr. Thomson
agrees with the use of nucleic acid ampliﬁcation testing for the diagnosis of group A
streptococcal pharyngitis but argues about the shortcomings of this technology if used
as a stand-alone test. Further he emphasized gaps in our knowledge in diagnosing
emerging agents of pharyngitis such as Fusobacterium spp. In a 2010 commentary [12],
he describes the important, often unseen role that doctoral-level clinical microbiolo-
gists play in quality patient care.”
Dr. Thomson has reduced his vocational commitment to 50% time and is poised to
retire at the end of 2018. He plans to remain active in written scholarship and fulﬁll
pending obligations to ASM, CAP, and CLSI. Importantly, he plans to spend additional
time with Nancy, his wife of 39 years, and their grandchildren and to further his hobbies
of photography, gardening, history, golﬁng, and restoring a family collection of bam-
boo ﬂy rods. He is also an avid philatelist and opines that his collection is in dire need
of reorganization. Thomson reﬂected that “microbiology has been an identity for me
and I’ll miss it” and hopes that technologists that have been family for all of these years
have enjoyed the times as much as he. He ultimately hopes to “tee up my laboratory
with structure and leadership that will push it ahead another 20 to 30 years.” In the
opinion of Thomson, the greatest challenge encountered by the ﬁelds of clinical and
medical microbiology is making sure our value is recognized. While it is true that clinical
microbiologists need to select and implement the latest technology and ensure that
each technologist is “trained, educated, and motivated,” we ultimately need to be that
interface or interpretive consultative service between result and clinician. On that note,
Thomson provides us with a ﬁnal thought: “Medical microbiologists need to do what no
one else in the hospital can do. If we are not recognized for these unique contributions,
we will disappear.”
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